ADHD, stimulant treatment in childhood and subsequent substance abuse in adulthood - A naturalistic long-term follow-up study

Addictive Behaviors

Volumn 39, Issue 1, 2014, Pages 325-328

  Dalsgaard, Søren ^a,b,c   Mortensen, Preben Bo ^a   Frydenberg, Morten ^a   Thomsen, Per Hove ^b  

^a AARHUS UNIVERSITY   (Denmark)

^b AARHUS UNIVERSITY HOSPITAL   (Denmark)

^c Hospital of Telemark   (Norway)

Author keywords

Alcohol; Attention deficit hyperactivity disorder (ADHD); Epidemiology; Methylphenidate; Pharmacoepidemiology; Substance use disorder

Indexed keywords

CANNABIS; DEXAMPHETAMINE; METHYLPHENIDATE; MORPHINE; OPIATE;

ADULT; ALCOHOL ABUSE; ALCOHOL USE DISORDER; ARTICLE; ATTENTION DEFICIT DISORDER; CHILDHOOD DISEASE; CONDUCT DISORDER; CONTROLLED STUDY; FEMALE; FOLLOW UP; HUMAN; JUVENILE; LONG TERM CARE; MAJOR CLINICAL STUDY; MALE; OPIATE ADDICTION; PROSPECTIVE STUDY; REGISTER; RISK FACTOR; SUBSTANCE ABUSE; TREATMENT DURATION;

ADHD; ALCOHOL; ATTENTION-DEFICIT/HYPERACTIVITY DISORDER; ATTENTION-DEFICIT/HYPERACTIVITY DISORDER (ADHD); CD; CONDUCT DISORDER; DANISH CIVIL REGISTRATION SYSTEM; DANISH PSYCHIATRIC CENTRAL REGISTER; DCRS; DIAGNOSTIC AND STATISTICAL MANUAL OF MENTAL DISORDERS; DPCR; DSM; EPIDEMIOLOGY; HAZARD RATIO; HR; ICD; INTERNATIONAL CLASSIFICATION OF DISEASES; METHYLPHENIDATE; ODD; OPPOSITIONAL DEFIANT DISORDER; PHARMACOEPIDEMIOLOGY; RELATIVE RISK; RR; SUBSTANCE USE DISORDER; SUD;

ADOLESCENT; ADULT; AGE FACTORS; ALCOHOLISM; ATTENTION DEFICIT DISORDER WITH HYPERACTIVITY; CENTRAL NERVOUS SYSTEM STIMULANTS; CHILD; CONDUCT DISORDER; DEXTROAMPHETAMINE; FEMALE; FOLLOW-UP STUDIES; HUMANS; LONGITUDINAL STUDIES; MALE; METHYLPHENIDATE; PROSPECTIVE STUDIES; RISK FACTORS; SEX FACTORS; SUBSTANCE-RELATED DISORDERS; YOUNG ADULT;

EID: 84890148772     PISSN: 03064603     EISSN: 18736327     Source Type: Journal    
DOI: 10.1016/j.addbeh.2013.09.002     Document Type: Article

References (41)

1. A.American Psychiatric Association Diagnostic and Statistical Manual of Mental Disorders, fourth edition (DSM-IV) 1994, Vol. 4.th. American Psychiatric Association, Washington, DC.
2. Arias A.J., Gelernter J., Chan G., Weiss R.D., Brady K.T., Farrer L., et al. Correlates of co-occurring ADHD in drug-dependent subjects: Prevalence and features of substance dependence and psychiatric disorders. Addictive Behaviors 2008, 33:1199-1207.
3. Barkley R.A., Fischer M., Smallish L., Fletcher K. Does the treatment of attention-deficit/hyperactivity disorder with stimulants contribute to drug use/abuse? A 13-year prospective study. Pediatrics 2003, 111:97-109.
4. Biederman J., Monuteaux M.C., Mick E., Spencer T., Wilens T.E., Silva J.M., et al. Young adult outcome of attention deficit hyperactivity disorder: A controlled 10-year follow-up study. Psychological Medicine 2006, 36:167-179.
5. Biederman J., Wilens T., Mick E., Faraone S.V., Weber W., Curtis S., et al. Is ADHD a risk factor for psychoactive substance use disorders? Findings from a four-year prospective follow-up study. Journal of the American Academy of Child and Adolescent Psychiatry 1997, 36:21-29.
6. Biederman J., Wilens T., Mick E., Spencer T., Faraone S.V. Pharmacotherapy of attention-deficit/hyperactivity disorder reduces risk for substance use disorder. Pediatrics 1999, 104:e20.
7. Bruckner T.A., Hodgson A., Mahoney C.B., Fulton B.D., Levine P., Scheffler R.M. Health care supply and county-level variation in attention-deficit hyperactivity disorder prescription medications. Pharmacoepidemiology and Drug Safety 2012, 21:442-449.
8. Burke J.D., Loeber R., Lahey B.B. Which aspects of ADHD are associated with tobacco use in early adolescence?. Journal Of Child Psychology And Psychiatry, And Allied Disciplines 2001, 42:493-502.
9. Castle L., Aubert R.E., Verbrugge R.R., Khalid M., Epstein R.S. Trends in medication treatment for ADHD. Journal of Attention Disorders 2007, 10:335-342.
10. Charach A., Yeung E., Climans T., Lillie E. Childhood attention-deficit/hyperactivity disorder and future substance use disorders: Comparative meta-analyses. Journal of the American Academy of Child and Adolescent Psychiatry 2011, 50:9-21.
11. Dalsgaard S., Hansen N., Mortensen P.B., Damm D., Thomsen P.H. Reassessment of ADHD in a historical cohort of children treated with stimulants in the period 1969-1989. European Child & Adolescent Psychiatry 2001, 10:230-239.
12. Dalsgaard S., Mortensen P.B., Frydenberg M., Thomsen P.H. Conduct problems, gender and adult psychiatric outcome of children with attention-deficit hyperactivity disorder. The British Journal of Psychiatry 2002, 181:416-421.
13. Dalsgaard S., Mortensen P.B., Frydenberg M., Thomsen P.H. Long-term criminality outcome of children with attention-deficit/hyperactivity disorder. Criminal Behaviour and Mental Health 2013, 23:86-98.
14. Dalsgaard S., Nielsen H.S., Simonsen M. Five-fold increase in national prevalence rates of ADHD medications for children and adolescents with autism spectrum disorder, attention-deficit/hyperactivity disorder and other psychiatric disorders. Journal of Child and Adolescent Psychopharmacology 2013, (E-pub). 10.1089/cap.2012.0111.
15. Dichter G.S., Damiano C.A., Allen J.A. Reward circuitry dysfunction in psychiatric and neurodevelopmental disorders and genetic syndromes: Animal models and clinical findings. Journal of Neurodevelopmental Disorders 2012, 4:19.
16. Disney E.R., Elkins I.J., McGue M., Iacono W.G. Effects of ADHD, conduct disorder, and gender on substance use and abuse in adolescence. The American Journal of Psychiatry 1999, 156:1515-1521.
17. Hansen S.S., Munk-Jorgensen P., Guldbaek B., Solgard T., Lauszus K.S., Albrechtsen N., et al. Psychoactive substance use diagnoses among psychiatric in-patients. Acta Psychiatrica Scandinavica 2000, 102:432-438.
18. Hechtman L., Weiss G. Controlled prospective fifteen year follow-up of hyperactives as adults: Non-medical drug and alcohol use and anti-social behaviour. Canadian Journal of Psychiatry 1986, 31:557-567.
19. Hechtman L., Weiss G., Perlman T., Amsel R. Hyperactives as young adults: Initial predictors of adult outcome. Journal of the American Academy of Child Psychiatry 1984, 23:250-260.
20. IBM Corp. IBM SPSS Statistics version 19.0.0 2010, Armonk, NY.
21. Juel K., Helweg-Larsen K. The Danish registers of causes of death. Danish Medical Bulletin 1999, 46:354-357.
22. Katusic S.K., Barbaresi W.J., Colligan R.C., Weaver A.L., Leibson C.L., Jacobsen S.J. Psychostimulant treatment and risk for substance abuse among young adults with a history of attention-deficit/hyperactivity disorder: A population-based, birth cohort study. Journal of Child and Adolescent Psychopharmacology 2005, 15:764-776.
23. Loney J., Whaley-Klahn M.A., Kosier T., Conboy J. Hyperactive boys and their brothers at 21: Predictors of aggressive and antisocial outcomes. Prospective studies of crime and delinquency 1983, 181. Kluwer-Nijhoff, Boston. K.T. Van Dusen, S.A. Mednick (Eds.).
24. Madsen A.G., Dalsgaard S. Prevalence of smoking, alcohol and substance use among adolescents with attention-deficit/hyperactivity disorder in Denmark compared with the general population. Nordic Journal of Psychiatry 2013, 1-7. Epub February 21st, 2013 ahead of print.
25. Mannuzza S., Klein R.G., Bessler A., Malloy P., LaPadula M. Adult psychiatric status of hyperactive boys grown up. The American Journal of Psychiatry 1998, 155:493-498.
26. Mannuzza S., Klein R.G., Truong N.L., Moulton J.L., Roizen E.R., Howell K.H., et al. Age of methylphenidate treatment initiation in children with ADHD and later substance abuse: Prospective follow-up into adulthood. The American Journal of Psychiatry 2008, 165:604-609.
27. Milberger S., Biederman J., Faraone S.V., Chen L., Jones J. ADHD is associated with early initiation of cigarette smoking in children and adolescents. Journal of the American Academy of Child and Adolescent Psychiatry 1997, 36:37-44.
28. Molina B.S., Flory K., Hinshaw S.P., Greiner A.R., Arnold L.E., Swanson J.M., et al. Delinquent behavior and emerging substance use in the MTA at 36months: Prevalence, course, and treatment effects. Journal of the American Academy of Child and Adolescent Psychiatry 2007, 46:1028-1040.
29. Molina B.S., Pelham W.E. Childhood predictors of adolescent substance use in a longitudinal study of children with ADHD. Journal of Abnormal Psychology 2003, 112:497-507.
30. Munk-Jorgensen P., Mortensen P.B. The Danish Psychiatric Central Register. Danish Medical Bulletin 1997, 44:82-84.
31. Paternite C.E., Loney J., Salisbury H., Whaley M.A. Childhood inattention-overactivity, aggression, and stimulant medication history as predictors of young adult outcomes. Journal of Child and Adolescent Psychopharmacology 1999, 9:169-184.
32. Pedersen C.B., Gøtzsche H., Møller J.Ø., Mortensen P.B. The Danish Civil Registration System - A cohort of eight million persons. Danish Medical Bulletin 2006, 53:441-449.
33. Volkow N.D., Wang G.J., Fowler J.S., Tomasi D. Addiction circuitry in the human brain. Annual Review of Pharmacology and Toxicology 2012, 52:321-336.
34. Weiss G. Follow-up studies on outcome of hyperactive children. Psychopharmacology Bulletin 1985, 21:169-177.
35. Wilens T. Attention-deficit/hyperactivity disorder and the substance use disorders: The nature of the relationship, subtypes at risk, and treatment issues. The Psychiatric Clinics of North America 2004, 27:283-301.
36. Wilens T.E. The nature of the relationship between attention-deficit/hyperactivity disorder and substance use. The Journal of Clinical Psychiatry 2007, 68(Suppl. 11):4-8.
37. Wilens T.E., Adamson J., Monuteaux M.C., Faraone S.V., Schillinger M., Westerberg D., et al. Effect of prior stimulant treatment for attention-deficit/hyperactivity disorder on subsequent risk for cigarette smoking and alcohol and drug use disorders in adolescents. Archives of Pediatrics & Adolescent Medicine 2008, 162:916-921.
38. Wilens T.E., Faraone S.V., Biederman J., Gunawardene S. Does stimulant therapy of attention-deficit/hyperactivity disorder beget later substance abuse? A meta-analytic review of the literature. Pediatrics 2003, 111:179-185.
39. World Health Organization International Classification of Diseases: Manual of the international statistical classification of diseases, injuries and causes of death (ICD-8) 1967, Vol. 8. WHO, Geneva, rev.
40. World Health Organization The ICD-10 classification of mental and behavioural disorders: Diagnostic criteria for research 1993, World Health Organization, Geneva, Switzerland.
41. Zuvekas S.H., Vitiello B., Norquist G.S. Recent trends in stimulant medication use among U.S. children. The American Journal of Psychiatry 2006, 163:579-585.